NCT03291028View on ClinicalTrials.gov

Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

RecruitingOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Renal Cell CarcinomaUrothelial CarcinomaBladder CancerUreter CancerUrethral Cancer
Interventions
BIOLOGICAL

Immune checkpoint inhibitor targeting PD1

RCC and UC patients treated with immune checkpoint blockade

Trial Locations (1)

19111-2497

RECRUITING

Fox Chase Cancer Center - Philadelphia, Philadelphia

All Listed Sponsors
lead

Fox Chase Cancer Center

OTHER